Use of substances that act as cascade inhibitors of the Raf/MEK/ERK signal cascade, for producing a medicament to treat infections by DNA and RNA viruses

Details for Australian Patent Application No. 2001262027 (hide)

International Classifications

Event Publications

9 March 2006 Application Accepted

Published as AU-B-2001262027

6 April 2006 Corrigenda

Applications Accepted - Name Index Under the name Medinnova Gesellschaft Fur Medizinische Innovationen Aus Akademischer Forschung MbH, Application No. 2001262027, under INID (54) correct the title to read Use of substances that act as cascade inhibitors of the Raf/MEK/ERK signal cascade, for producing a medicament to treat DNA and RNA viruses. Specifications Republished The following specifications contained errors when advertised OPI, Accepted or Certified. They have been reissued on the AU-A or AU-B CD-RO

27 April 2006 Assignment before Grant

Medinnova Gesellschaft Fur Medizinische Innovationen Aus Akademischer Forschung MbH The application has been assigned to Activaero GmbH

6 July 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.